The third patient with a pathogenic germline BRCA1 mutation and anal squamous cell carcinoma did not possess a somatic BRCA alteration, but the BRCA1 RNA expression was low (16th percentile) in the tumor, suggesting a potential silencing of the wild-type allele by epigenetic mechanisms such as methylation. This evidence concerns the gene BRCA1 and anal squamous cell carcinoma.